Myopia Control With a Innovative Spectacle Lens - A Cessation Study

Condition(s) studied

Investigational drug(s) / intervention(s)

Single Vision Lens to A innovative spectacle lens: Participants in this arm are from the test group of the previous clinical trial (NCT05174780), where they wore the innovative spectacle lenses for three years. They will now wear single vision lenses for 12 months.

Single Vision Lens to A innovative spectacle lens: Participants in this arm are from the control group of the previous clinical trial (NCT05174780), where they wore the single vision spectacle lenses for three years. They will now wear single vision lenses for another 12 months.

Study summary

The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.

Eligibility

Primary outcome measure(s)

• Change in cycloplegic spherical equivalent refraction from baseline — 0 - 12 months
• Change in Axial Length from baseline — 0 - 12 months

Trial sites (5)